Jazz Pharmaceuticals, Inc. (JAZZ) Misses Q3 EPS by 3c; Guides Slightly Below the Street

November 8, 2012 4:36 PM

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q3 EPS of $1.29, $0.03 worse than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found